CEP57 mutation in a girl with mosaic variegated aneuploidy syndrome
- 20 November 2013
- journal article
- case report
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 164 (1) , 177-181
Abstract
Mosaic variegated aneuploidy (MVA) is a rare autosomal recessive disorder characterized by constitutional aneuploidies. Mutations in BUB1B and CEP57 genes, which are involved in mitotic spindle and microtubule stabilization, respectively, are responsible for a subset of patients with MVA. To date, CEP57 mutations have been reported only in four probands. We report on a girl with this disorder due to c.915‐925dup11 mutation in CEP57, which predicts p.Leu309ProfsX9 and review the literature in order to facilitate genotype–phenotype correlation. Rhizomelic shortening of the upper limbs, skull anomalies with conserved head circumference, and absence of tumor development could be features suggesting a need for molecular screening of the CEP57 gene in patients with this disorder.Keywords
This publication has 7 references indexed in Scilit:
- Mutations in CEP57 cause mosaic variegated aneuploidy syndromeNature Genetics, 2011
- CraniosynostosisEuropean Journal of Human Genetics, 2011
- Xenopus Cep57 Is a Novel Kinetochore Component Involved in Microtubule AttachmentCell, 2007
- Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1BNature Genetics, 2004
- Translokin is an intracellular mediator of FGF-2 traffickingNature Cell Biology, 2003
- Mad2-Independent Inhibition of APCCdc20 by the Mitotic Checkpoint Protein BubR1Developmental Cell, 2001
- Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vaultDevelopment, 1999